According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, abdominal pain, and reduced appetite
Patients with MASLD or MASH may benefit from more structured monitoring, including non-invasive assessments of liver fibrosis such as FIB-4 index calculation or vibration-controlled transient elastography (FibroScan) when available
Taylor JL, Bonikowske AR, Olson TP
With the aid of shotgun sequencing of fecal samples and targeted metabolomics profiling of serum samples in CKD patients of different stages and non-CKD controls, Wu et al
The catalytic activity is only initiated when an association is established, in balance status, between the dimeric and tetrameric 6 forms
All others are injections and have the added benefit of weight loss, like Trulicity (dulaglutide) and Victoza (liraglutide)